The 1 reports from 1 analysts offering long term price targets
for Advanced Enzyme Technologies Ltd. have an average target of 222.00. The consensus estimate
represents a downside of -11.57%
from the last price of 251.05.
ADVENZY delivered topline growth of 8% yoy to Rs1.11bn in Q2FY20, largely in line with our estimates. EBITDA margins improved by 158bps yoy to 42.4% due to better operational efficiencies. PAT increased by 25% yoy to Rs310mn. On the segmental front, Human Healthcare grew 7% yoy, Animal HealthCare rose 9% yoy and Bio processing clocked 13% yoy growth. On the geographical front, Europe and India have done well with 51% and 14% yoy growth, respectively. its clients amid a weak economy. However, it remains confident of achieving ~10% yoy revenue growth and EBITDA margins in the range of 41-45% for FY20....
Advanced Enzymes' (ADVENZY) Q4FY18 results were in line with our estimate. Revenue stood at Rs1.08bn, up 26% yoy (Emkay Est: Rs1.08bn). US, India, Asia, Europe and Others geographies grew by 36%, 7%, 281%, 27% and 154% yoy, respectively. Revenue growth was driven by Human Nutrition (+36% yoy | 76% of revenue), Industrial Processing (+27% yoy | 5% of Rev.) and Animal Healthcare (5% yoy | 14% of Rev);...
AETL is integrated company with presence across the Enzyme value chain having specialised business with high entry barriers. It has strong R&D;, Enzyme Development and Manufacturing capabilities with diversified product portfolio (more than 400 propreitary products) and wide customer base (700 customers worldwide). Having financial stability and stable cash flow, AETL has broadened and deepened the geographical presence. AETL Ranks among the top 15 global companies in terms of enzyme sales, and has the 2nd highest market share domestically,nextonlytotheworld'slargestenzymecompanyNovozymes.Ithas7...
We met the management of Advanced Enzyme Technologies (AET) to understand its business model and future prospects. AET is one of the largest research driven Indian enzyme companies with more than two decades of experience in the fermentation process for producing enzymes. It is engaged in the R&D;, manufacturing and marketing of more than 400 proprietary enzyme products developed from 68+ indigenous enzymes operating in two primary business verticals viz. 1) healthcare and nutrition: human (72% of revenue) animal (15%) and 2) bioprocessing: food (7%) and non-food (6%). It offers these products to...
Advanced Enzyme Technologies Ltd (AETL) is the largest Indian enzyme company, engaged in the research and development, manufacturing and marketing of 400+ proprietary products developed from 60 indigenous enzymes. AETL ranks among the top 15 global companies in terms of enzyme sales, and has the second highest market share domestically, next only to the world’s largest enzyme company Novozymes and operates in two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food). It is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (“R&D”) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost- effective unique and innovative solutions, thereby enabling its customers to develop superior products and processes.
Advanced Enzyme Technologies (AET) is one of the largest research driven Indian enzyme companies with more than two decades of experience in the fermentation process for production of enzymes. It is engaged in R&D, manufacturing and marketing of more than 400 proprietary enzyme products developed from 60 indigenous enzymes operating in two primary business verticals namely healthcare and nutrition (human and animal) and bio-processing (food and non-food). It offers these products to a global clientele of more than 700 customers across 50 countries worldwide. The company manufactures enzymes by using all four existing natural origins viz. plant, fungal, bacterial and animal sources, using environment-friendly biotechnology processes.At the IPO price band of | 880-896, the stock is available at 25.5-29.6x of FY16 EPS of | 35.1-29.6.
Advanced Enzyme Technologies (AET) is the second largest enzyme company in India and amongst the Top 15 global enzyme companies with a market share of ~0.9%. The company is engaged in research & development, manufacturing and marketing of 400+ proprietary products developed from 60 indigenous enzymes. Specialized business with high en..
It has fully integrated enzyme manufacturing company driven by extensive focus on R&D; of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Company's experienced and qualified R&D; team consists of more than 55 members comprising of scientists, microbiologists, engineers, food technologists, biotechnologists...
Advanced Enzyme Technologies Ltd is engaged in the research and development, manufacturing and marketing of 400+ proprietary products developed from 60 indigenous enzymes. The company has the second highest market share domestically, next only to the world's largest enzyme company Novozymes. It is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D;) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Advanced Enzyme has two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food). Healthcare & Nutrition segment contributes to nearly 88% of revenues as of FY16 and the core focus of the management lies here. In human Healthcare & Nutrition, the company's enzymes are used as active...
